Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers.
about
Visualizing epigenetics: current advances and advantages in HDAC PET imaging techniquesHDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cellsPhospholipase D1 and choline kinase-α are interactive targets in breast cancer.Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with TemozolomideAcquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours.Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopyAcute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.Targeting Phospholipid Metabolism in Cancer.MCT1 Inhibitor AZD3965 Increases Mitochondrial Metabolism, Facilitating Combination Therapy and Noninvasive Magnetic Resonance Spectroscopy.Characterization of the response of taurine protons to PRESS at 9.4 T for Resolving choline and Determining taurine T2.Metabolomic Profiling Reveals Cellular Reprogramming of B-Cell Lymphoma by a Lysine Deacetylase Inhibitor through the Choline Pathway.
P2860
Q26862755-07AA2482-3D1F-49E9-B4E1-6B01E5EB3A72Q28486529-1DE090F2-99DA-47B6-B4ED-369FE96B989AQ33631482-524C6999-D1E1-491D-A988-1CA6B265BF72Q33842777-1756FBCC-45DE-4F8A-ACCE-FBA2D3E71A63Q34318242-9280AE1A-12AE-484E-9C64-7093B2529798Q35275024-40862EE7-E6A9-45D8-972A-05BEBC75DAA9Q35497704-FA5E0DDA-36E3-4D39-B611-30CFDFA5441FQ37182194-2308230A-D14E-46C3-94B1-96CF16163C42Q39084885-B6555860-F39D-4C2B-B14D-C799E18F84FFQ43296499-CABF64B6-35E0-4B95-B3EA-E3F6328E9011Q48585536-DB6E3AB6-B5B0-4349-9DE7-F7B270B5CDDBQ49359645-52FE0C99-82F4-4012-B944-B70D02CB8DAF
P2860
Histone deacetylase inhibition increases levels of choline kinase α and phosphocholine facilitating noninvasive imaging in human cancers.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Histone deacetylase inhibition ...... sive imaging in human cancers.
@ast
Histone deacetylase inhibition ...... sive imaging in human cancers.
@en
Histone deacetylase inhibition ...... sive imaging in human cancers.
@nl
type
label
Histone deacetylase inhibition ...... sive imaging in human cancers.
@ast
Histone deacetylase inhibition ...... sive imaging in human cancers.
@en
Histone deacetylase inhibition ...... sive imaging in human cancers.
@nl
prefLabel
Histone deacetylase inhibition ...... sive imaging in human cancers.
@ast
Histone deacetylase inhibition ...... sive imaging in human cancers.
@en
Histone deacetylase inhibition ...... sive imaging in human cancers.
@nl
P2093
P2860
P1433
P1476
Histone deacetylase inhibition ...... sive imaging in human cancers.
@en
P2093
Anne-Christine Wong te Fong
Geoffrey S Payne
Helen Troy
Ian R Judson
John R Griffiths
L Elizabeth Jackson
Martin O Leach
Mounia Beloueche-Babari
Robert H te Poele
Vaitha Arunan
P2860
P304
P356
10.1158/0008-5472.CAN-11-2688
P407
P50
P577
2011-12-22T00:00:00Z